Medexus Pharmaceuticals Inc.
MDP.TOTSXHealthcare● Active
$3.95
+$0.04(+1.02%)
Market Cap$127586501
P/E Ratio—
52W High$4.17
52W Low$2.47
Medexus Pharmaceuticals Inc. (MDP.TO) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · MDP.TO · as of 2026-06-15
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.02B | $0.01B | $0.01B | $0.01B | $0.02B |
| Net Receivables | $0.01B | $0.02B | $0.03B | $0.01B | $0.02B |
| Inventory | $0.04B | $0.03B | $0.02B | $0.02B | $0.01B |
| Total Current Assets | $0.08B | $0.07B | $0.07B | $0.05B | $0.06B |
| PP&E Net | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Goodwill | $0.01B | $0.01B | $0.01B | $0.01B | $0.01B |
| Intangible Assets | $0.07B | $0.06B | $0.07B | $0.08B | $0.08B |
| Total Assets | $0.17B | $0.16B | $0.16B | $0.14B | $0.15B |
| Liabilities | |||||
| Short-Term Debt | $0.04B | $0.02B | $0.04B | $0.02B | $0.01B |
| Accounts Payable | $0.01B | $0.01B | $0.01B | $0.02B | $0.01B |
| Total Current Liabilities | $0.10B | $0.07B | $0.08B | $0.05B | $0.04B |
| Long-Term Debt | $0.00B | $0.03B | $0.03B | $0.04B | $0.03B |
| Total Liabilities | $0.12B | $0.13B | $0.14B | $0.12B | $0.13B |
| Stockholders Equity | |||||
| Retained Earnings | ($0.06B) | ($0.06B) | ($0.06B) | ($0.07B) | ($0.06B) |
| Total Stockholders Equity | $0.05B | $0.03B | $0.02B | $0.02B | $0.02B |
| Total Liab & Equity(computed) | $0.17B | $0.16B | $0.16B | $0.14B | $0.15B |
| Debt Summary | |||||
| Total Debt | $0.04B | $0.05B | $0.07B | $0.05B | $0.04B |
| Net Debt | $0.01B | $0.04B | $0.08B | $0.04B | $0.03B |
Data source: Financial Modeling Prep · Last updated: 2026-06-15 · USD · B
Explore more Medexus Pharmaceuticals Inc. data
About Medexus Pharmaceuticals Inc. (MDP.TO) Balance Sheet
Medexus Pharmaceuticals Inc. (MDP.TO) balance sheet shows total assets of $0.17B with cash of $0.02B. Total liabilities are $0.12B, total debt $0.04B, and stockholders equity $0.05B.
Frequently asked questions
MDP.TO · 4 questionsMedexus Pharmaceuticals Inc. has total debt of $0.04B with net debt of $0.01B.
MDP.TO total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15